Trade ABEO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Abeona Therapeutics Inc. (ABEO) is trading at US$5.98, down 0.33% today as of Sep 8, 12:23 EDT. The company has a market capitalisation of US$348.25M. Over the past 52 weeks, ABEO has traded between US$4.00 and US$7.65. On Syfe you can trade ABEO with $0 commission and add it to your watchlist.
| Previous close | US$6.00 |
|---|---|
| Market cap | US$348.25M |
| 52-week range | US$4.00 – US$7.65 |
| Volume | 866.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Abeona Therapeutics Inc.
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
Year: 1980
Abeona Therapeutics Inc. (ABEO) stock is trading at US$5.98, -0.33% from the previous close of US$6.00.
The market cap for Abeona Therapeutics Inc. (ABEO) stock is approximately US$348.25M.
The 52-week high for Abeona Therapeutics Inc. (ABEO) stock is US$7.65.
The 52-week low for Abeona Therapeutics Inc. (ABEO) stock is US$4.00.
Abeona Therapeutics Inc. (ABEO) does not currently pay a dividend.
Stay on top of ABEO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
